Cedars-Sinai Cancer at SOCC — Los Angeles, California

Cedars-Sinai Cancer at SOCC is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Cedars-Sinai Cancer at SOCC has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: High-risk Prostate Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer.

Sponsors: Edwin Posadas, MD, Arsen Osipov, Karen Reckamp, MD, MS.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedars-Sinai Cancer at SOCC?

Cedars-Sinai Cancer at SOCC has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedars-Sinai Cancer at SOCC conducted?

Cedars-Sinai Cancer at SOCC has 3 clinical trials on record, with 3 currently active. Their work covers High-risk Prostate Cancer, Metastatic Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer.

Is Cedars-Sinai Cancer at SOCC accredited by Crixeo Health?

Cedars-Sinai Cancer at SOCC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cedars-Sinai Cancer at SOCC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.